Notice: Constant SD_FRAMEWORK already defined in /nas/content/live/sgoodwinmulti/wp-content/themes/myuniversity/functions.php on line 7

Notice: Constant SD_FRAMEWORK_INC already defined in /nas/content/live/sgoodwinmulti/wp-content/themes/myuniversity/functions.php on line 8

Notice: Constant SD_FRAMEWORK_CSS already defined in /nas/content/live/sgoodwinmulti/wp-content/themes/myuniversity/functions.php on line 9

Notice: Constant SD_FRAMEWORK_JS already defined in /nas/content/live/sgoodwinmulti/wp-content/themes/myuniversity/functions.php on line 10

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the sd-framework domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/sgoodwinmulti/wp-includes/functions.php on line 6114

Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /nas/content/live/sgoodwinmulti/wp-content/plugins/js_composer/include/classes/core/class-vc-mapper.php on line 111

Warning: Declaration of kcWalker_Terms::start_el(&$output, $term, $depth, $args, $id = 0) should be compatible with Walker::start_el(&$output, $data_object, $depth = 0, $args = Array, $current_object_id = 0) in /nas/content/live/sgoodwinmulti/wp-content/plugins/kc-settings/kc-settings-inc/options.php on line 158

Warning: Declaration of kcWalker_Posts::start_el(&$output, $post, $depth, $args, $id = 0) should be compatible with Walker::start_el(&$output, $data_object, $depth = 0, $args = Array, $current_object_id = 0) in /nas/content/live/sgoodwinmulti/wp-content/plugins/kc-settings/kc-settings-inc/options.php on line 169
Steven Tjoe, Sukrti Thonse, Author at Life Sciences Perspectives

Search Results for:
Notice: Undefined variable: brand_name in /nas/content/live/sgoodwinmulti/wp-content/themes/myuniversity-child/framework/inc/page-top.php on line 87

Notice: Undefined variable: scientific_name in /nas/content/live/sgoodwinmulti/wp-content/themes/myuniversity-child/framework/inc/page-top.php on line 87

Notice: Undefined variable: company_name in /nas/content/live/sgoodwinmulti/wp-content/themes/myuniversity-child/framework/inc/page-top.php on line 87

Notice: Undefined variable: litigation in /nas/content/live/sgoodwinmulti/wp-content/themes/myuniversity-child/framework/inc/page-top.php on line 87

Notice: Undefined variable: post_category in /nas/content/live/sgoodwinmulti/wp-content/themes/myuniversity-child/framework/inc/page-top.php on line 87

image_pdf

FDA Publishes Its First Draft Guidance On Use of Artificial Intelligence in the Development of Drugs and Biological Products

On January 7, 2025, the FDA issued a draft guidance called Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products. The document clarifies how sponsors, manufacturers, and other industry developers should approach artificial intelligence (AI) to support safe, effective development and marketing of AI-based…

Read More

How to (Finally) Get Your SIUU Out: FDA Issues Final Guidance on Communicating Off-Label Scientific Information

On January 7, 2025, FDA announced the availability of a final guidance document titled “Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products.” The final guidance supersedes the agency’s revised draft guidance of the same title issued in October 2023 (see our…

Read More

New Momentum for a Time-Limited Conditional Approval Pathway for Rare Disease Drugs

On October 4, 2024, a US House version of the revised Promising Pathway Act (PPA) 2.0 was introduced, sponsored by Rep. Bruce Westerman (R-AR). The bill (H.R.9938) mirrors a US Senate version that was introduced in May 2024 (S.4426) that would authorize the US Food  and Drug Administration (FDA) to…

Read More

FDA Issues Final Rule on Regulation of Laboratory Developed Tests

On April 29, 2024, the U.S Food and Drug Administration (FDA) announced its final rule on Laboratory Developed Tests (LDTs). This final ruling amends the FDA’s regulations to make explicit that in vitro diagnostic products (IVDs), including those manufactured by laboratories, are devices under the Federal Food, Drug, and Cosmetic…

Read More